Investigating this topic through rigorous studies is crucial to gaining a more concrete understanding of any potential links between semaglutide use and menstrual irregularities
Although semaglutide is not approved for use during pregnancy, the FDA recommends discontinuation at least two months prior to conception based on preclinical evidence of embryotoxicity
For those seeking stronger results, retatrutide injection represents a more potent alternative activating multiple metabolic pathways
Frequently Asked Questions (FAQs) 1
Kim SH, Kandiah N, Hsu JL, Suthisisang C, Udommongkol C, Dash A
[5] Importantly, if both B12 and folate deficiencies are present, B12 should be corrected first to avoid potentially worsening neurological symptoms